Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
24.70
+0.11 (0.45%)
Jun 12, 2026, 1:43 PM EDT - Market open
Arcutis Biotherapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Reiterates $35 | Buy | Reiterates | $35 | +41.70% | Jun 3, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $35 | Buy | Maintains | $35 | +41.70% | May 26, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $34 | Buy | Reiterates | $34 | +37.65% | May 11, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $35 → $34 | Buy | Maintains | $35 → $34 | +37.65% | May 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $35 | Buy | Maintains | $35 | +41.70% | May 7, 2026 |
| Needham | Needham | Buy Maintains $36 | Buy | Maintains | $36 | +45.75% | May 7, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Reiterates $31 → $35 | Buy | Reiterates | $31 → $35 | +41.70% | Mar 9, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $29 → $33 | Hold | Maintains | $29 → $33 | +33.60% | Feb 27, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.